Clinical Trial

An Interventional Left Ventricular Assist System for Cardiogenic Shock

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 8, 2024 (before its estimated November 8, 2025 completion). Its status may not reflect the trial's current state.
Summary
Imported Impella The price is relatively expensive and difficult for ordinary patients to afford. In order to better meet the growing clinical needs in China, Anhui Tongling Bionic Technology Co., Ltd. has developed an interventional left ventricular assist system. The test device was tested in preclinical animals It has shown good effectiveness and safety. Through the implementation of this clinical trial, the interventional left ventricular assist system The safety and effectiveness of the system for hemodynamic support in patients with cardiogenic shock have led to further development of this product in the country.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06127927
Lead Sponsor Fujian Medical University
Conditions Cardiogenic Shock
Enrollment 60 participants
Start Date 2023-11-08
Primary Completion 2025-11-08 (estimated)
Study Completion 2025-12-08 (estimated)
Updated on ClinicalTrials.gov 2024-07-08